Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PathoGene
AddedFeb 18, 2024
UpdatedJun 18, 2026
PathoGene

PathoGene

Seed

PathoGene, Inc.: A seed-stage MedTech startup developing a rapid, comprehensive diagnostic device for infectious diseases.

HQ
Monrovia, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees

PathoGene, Inc. is a seed-stage MedTech startup based in Los Angeles, with R&D in Monrovia, California. The company focuses on developing a sample-to-answer in vitro diagnostic device that detects and identifies all known microscopic human pathogens and their antimicrobial resistance profiles within six hours. Utilizing robotic automation, third-generation DNA and RNA sequencing, and cloud computing, PathoGene aims to revolutionize infectious disease diagnostics.

PathoGene has made significant strides in precision medicine by integrating advanced technologies to provide rapid and comprehensive diagnostic solutions. Their innovative approach has the potential to significantly impact patient outcomes and healthcare efficiency. The company is supported by a dedicated team of experts in biotechnology and medical diagnostics, driving forward its mission to enhance global health through cutting-edge diagnostic tools.

PathoGene - Similar Companies

OmniVis logo

OmniVis

GeneCapture logo

GeneCapture

genecapture.com

PathogenDx logo

PathogenDx

pathogendx.com

Pathware logo

Pathware

pathware.com

Pathogenetix logo

Pathogenetix

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

MicrobeDx logo

MicrobeDx

microbedx.com

Spectral Platforms logo

Spectral Platforms

Nanopath logo

Nanopath

nanopathdx.com

Guanine logo

Guanine

guanineinc.com

PhageTech logo

PhageTech

phagetech.com

Instapath Inc. logo

Instapath Inc.

instapathbio.com

Karius logo

Karius

kariusdx.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Day Zero Diagnostics logo

Day Zero Diagnostics

PathoGene - Quick Facts

Who are PathoGene's competitors?

Companies similar to PathoGene include OmniVis, GeneCapture, PathogenDx and Pathware.

When was PathoGene founded?

PathoGene was founded in 2020.

Where is PathoGene's headquarters located?

PathoGene's headquarters is located in Monrovia, CA, US.

When was PathoGene's last funding round?

PathoGene's most recent funding round was for $500k (USD) in July 2021.

How much has PathoGene raised to-date?

As of Jul 14, 2021, PathoGene has raised a total of $500k (USD).

How many employees does PathoGene have?

PathoGene has 9 employees as of Feb 4, 2024.

PathoGene - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • North America
Revenue
  • Software
Main Product
  • Diagnostics
  • Medical Devices
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified